Hippocratic AI, Inc.

Hippocratic AI is a privately held technology company specializing in safety-focused generative AI for the healthcare sector. Founded in 2023, the company's mission is to enhance healthcare accessibility and improve patient outcomes globally by leveraging artificial intelligence to address the worldwide shortage of healthcare professionals. Headquartered in Palo Alto, California, Hippocratic AI aims to bring deep healthcare expertise to every individual through its innovative solutions.

The company develops non-diagnostic, patient-facing clinical AI agents designed to handle low-risk tasks. These agents assist with functions such as chronic care management, post-discharge follow-ups, medication reminders, patient intake screening, and pre-operative planning. Hippocratic AI explicitly states that its agents do not diagnose or prescribe. The company serves a broad market including health systems, payors, and pharmaceutical firms, utilizing its proprietary "Polaris Safety Constellation Architecture" which employs multiple specialized Large Language Models (LLMs) to ensure safety and validation in patient interactions. It has also launched a Healthcare AI Agent App Store to empower clinicians in designing AI solutions.

Led by co-founder and CEO Munjal Shah, Hippocratic AI has experienced rapid growth since its inception. The company secured $126 million in Series C funding in November 2025, valuing it at $3.5 billion and bringing its total funding to $404 million. This followed a $141 million Series B round in January 2025. In January 2026, Hippocratic AI acquired Grove AI to strengthen its life sciences division. The company has partnered with over 50 health systems, payers, and pharmaceutical firms across six countries, reporting over 115 million patient interactions without safety incidents. Its AI models are noted for outperforming general-purpose LLMs on various medical certifications.